MONTREAL, March 30, 2026 /CNW/ - Novartis Pharmaceuticals Canada Inc. ("Novartis Canada") is calling on Canadian early‑career oncology clinicians and researchers to submit abstracts for the 2026 Novartis Oncology Young Canadian Investigator Awards (NOYCIA), a national program dedicated to supporting and recognizing emerging oncology researchers across Canada.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Novartis Canada Reopens NOYCIA 2026, Continuing Its Longstanding Investment in the Future of Oncology Research
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
